A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD
NCT ID: NCT00242333
Last Updated: 2006-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
300 participants
INTERVENTIONAL
2005-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AD 237
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Post-bronchodilator FEV1 at no more than 65% and at least 30% of the predicted normal value.
* Pre-bronchodilator FEV1/FVC ratio of less than 70%.
* Current or ex-smokers with a smoking history of at least 10 pack years.
Exclusion Criteria
* Other serious respiratory or other medical conditions which may interfere with the outcome of the study.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis
INDUSTRY
Sosei
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert G Tansley, MD
Role: STUDY_DIRECTOR
Arakis Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Specialized Hospital for Active Treatment Pneumophthysiatric Disease "Kudoglu"
Plovdiv, , Bulgaria
Regional Dispensary for Pulmonary Diseases Rousse
Rousse, , Bulgaria
5-th Multiprofile Hospital for Active Treatment
Sofia, , Bulgaria
MHAT "Alexandrovska"
Sofia, , Bulgaria
Specialized Hospital for Active Treatment of Pulmonary Diseases "Sveta Sofia"
Sofia, , Bulgaria
Central Clinical Base - Medical Institute - Ministry of the Interior
Sofia, , Bulgaria
Military Medical Academy
Sofia, , Bulgaria
UMHAT "Stara Zagora" EAD
Stara Zagora, , Bulgaria
University Hospital
Varna, , Bulgaria
Tudogyintezete Nodradgardony
Balassagyarmat, , Hungary
III. district Outpatient Clinic
Budapest, , Hungary
Diagnostic Units Hungary Ltd
Budapest, , Hungary
Gyogyir XI. Kht.II. Tudogondozo Intezet
Budapest, , Hungary
Selye Janos Hospital
Komárom, , Hungary
Karolona Hospital
Mosonmagyaróvár, , Hungary
Szabolcs Szatmar Bereg Megyei Josa Andras Korhaz
Nyíregyháza, , Hungary
Fejer County Szent Gyorgy Hospital
Székesfehérvár, , Hungary
Vas County Markusovszky Hospital
Szombathely, , Hungary
Szpital Wojewodzki
Bielsko-Biala, , Poland
10 Wojskowy Szpital Kliniczny Z Poliklinika
Bydgoszcz, , Poland
Samodzielny Publiczny Centralny Szpital Kliniczny SAM
Katowice, , Poland
Specjalistyczny Osrodek Alergologiczny ALL-MED
Krakow, , Poland
Barlicki University Hospital
Lodz, , Poland
Szpital ZOZ
Oława, , Poland
Wielkopolskie Centrum Chorob Pluc I Gruzlicy
Poznan, , Poland
Specjalistyczna Przychodnia Lekarska "Medikard"
Płock, , Poland
Spitalul Clinic de Urgenta Floreasca
Bucharest, , Romania
Spitalul de Pneumo Ftiziologie "Sf. Stefan"
Bucharest, , Romania
Spitalul Clinic "Colentina"
Bucharest, , Romania
Institutul National de Boli Infectioase
Bucharest, , Romania
Spitalul Clinic de Boli Infectioase si Tropicale " Dr. Victor Babes "
Bucharest, , Romania
Institutul de Pneumologie " Marius Nasta "
Bucharest, , Romania
Spitalul Clinic de Urgenta Constanta
Constanța, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-AD237-005
Identifier Type: -
Identifier Source: org_study_id